1. Alemtuzumab consolidation in chronic lymphocytic leukaemia: a phase I/II multicentre trial. (1st December 2016) Authors: Al‐Sawaf, Othman; Fischer, Kirsten; Herling, Carmen D.; Ritgen, Matthias; Böttcher, Sebastian; Bahlo, Jasmin; Elter, Thomas; Stilgenbauer, Stephan; Eichhorst, Barbara F.; Busch, Raymonde; Elberskirch, Ute; Abenhardt, Wolfgang; Kneba, Michael; Hallek, Michael; Wendtner, Clemens‐Martin Journal: European journal of haematology Issue: Volume 98:Number 3(2017:Mar.) Page Start: 254 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Effects of Exercise Interventions and Physical Activity Behavior on Cancer Related Cognitive Impairments: A Systematic Review. (10th April 2016) Authors: Zimmer, Philipp; Baumann, Freerk T.; Oberste, Max; Wright, Peter; Garthe, Alexander; Schenk, Alexander; Elter, Thomas; Galvao, Daniel A.; Bloch, Wilhelm; Hübner, Sven T.; Wolf, Florian Other Names: Bocalini Danilo S. Academic Editor. Journal: BioMed research international Issue: Volume 2016(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluating The Suitability Of A Graded Exercise Test In Patients With Acute Leukemia Or Lymphoma: 1240 Board #366 May 27 2:30 PM ‐ 4:00 PM. (July 2020) Authors: Großek, Anja; Oberste, Max; Bloch, Wilhelm; Wolf, Florian; Hallek, Michael; Elter, Thomas; Zimmer, Philipp Journal: Medicine and science in sports and exercise Issue: Volume 52(2020)Supplement 7 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Feasibility and Potential Benefits of an Exercise Intervention in a Male With Down Syndrome Undergoing High-Dose Chemotherapy for Acute Lymphoblastic Leukemia: A Case Report. (February 2019) Authors: Bühl, Linda; Abel, Thomas; Wolf, Florian; Oberste, Max; Bloch, Wilhelm; Hallek, Michael; Elter, Thomas; Zimmer, Philipp Journal: Integrative cancer therapies Issue: Volume 18(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Impact of exercise on pro inflammatory cytokine levels and epigenetic modulations of tumor‐competitive lymphocytes in Non‐Hodgkin‐Lymphoma patients‐randomized controlled trial. (28th June 2014) Authors: Zimmer, Philipp; Baumann, Freerk T.; Bloch, Wilhelm; Schenk, Alexander; Koliamitra, Christine; Jensen, Patrizia; Mierau, Andreas; Hülsdünker, Thorben; Reinart, Nina; Hallek, Michael; Elter, Thomas Journal: European journal of haematology Issue: Volume 93:Number 6(2014:Dec.) Page Start: 527 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Impact of induction chemotherapy on objective and self-perceived cognitive performance in patients suffering from hematological disorders. Issue 10 (24th August 2021) Authors: Zimmer, Philipp; Hillebrand, Philipp; Wolf, Florian; Joisten, Niklas; Walzik, David; Hardt, Luca; Großek, Anja; Hartig, Philipp; Kierdorf, Fiona; Belz, Maximilian; Tinschmann, Malina; Kiesl, David; Bloch, Wilhelm; Groß-Ophoff-Müller, Carolin; Hallek, Michael; Böll, Boris; Oberste, Max; Elter, Thomas Journal: Leukemia & lymphoma Issue: Volume 62:Issue 10(2021) Page Start: 2526 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Individually tailored whole-body vibration training to reduce symptoms of chemotherapy-induced peripheral neuropathy: study protocol of a randomised controlled trial—VANISH. Issue 4 (24th April 2019) Authors: Streckmann, Fiona; Hess, Viviane; Bloch, Wilhelm; Décard, Bernhard F; Ritzmann, Ramona; Lehmann, Helmar C; Balke, Maryam; Koliamitra, Christina; Oschwald, Vanessa; Elter, Thomas; Zahner, Lukas; Donath, Lars; Roth, Ralf; Faude, Oliver Journal: BMJ open Issue: Volume 9:Issue 4(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. L-kynurenine as a prognostic marker for early mortality in patients with acute myeloid leukemia. Issue 8 (3rd July 2022) Authors: Kierdorf, Fiona; Zimmer, Philipp; Joisten, Niklas; Kiesl, David; Winker, Matteo; Rigoux, Lionel; Elter, Thomas Journal: Leukemia & lymphoma Issue: Volume 63:Issue 8(2022) Page Start: 2001 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Post-chemotherapy cognitive impairment in patients with B-cell non-Hodgkin lymphoma: a first comprehensive approach to determine cognitive impairments after treatment with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone or rituximab and bendamustine. Issue 2 (February 2015) Authors: Zimmer, Philipp; Mierau, Andreas; Bloch, Wilhelm; Strüder, Heiko K.; Hülsdünker, Thorben; Schenk, Alexander; Fiebig, Leonie; Baumann, Freek T.; Hahn, Moritz; Reinart, Nina; Hallek, Michael; Elter, Thomas Journal: Leukemia & lymphoma Issue: Volume 56:Issue 2(2015:Feb.) Page Start: 347 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗